Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 3
1951 3
1955 1
1957 2
1965 4
1966 1
1969 2
1971 2
1972 2
1973 1
1979 1
1983 1
1984 2
1986 1
1987 1
1988 2
1989 3
1990 5
1991 8
1992 10
1993 10
1994 5
1995 2
1996 5
1997 6
1998 10
1999 8
2000 7
2001 9
2002 9
2003 11
2004 10
2005 7
2006 13
2007 11
2008 18
2009 11
2010 16
2011 22
2012 18
2013 21
2014 17
2015 16
2016 23
2017 24
2018 29
2019 28
2020 24
2021 29
Text availability
Article attribute
Article type
Publication date

Search Results

440 results
Results by year
Filters applied: . Clear all
Page 1
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group. Pi-Sunyer X, et al. Among authors: fujioka k. N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892. N Engl J Med. 2015. PMID: 26132939 Free article. Clinical Trial.
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group. le Roux CW, et al. Among authors: fujioka k. Lancet. 2017 Apr 8;389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7. Epub 2017 Feb 23. Lancet. 2017. PMID: 28237263 Clinical Trial.
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E; COR-I Study Group. Greenway FL, et al. Among authors: fujioka k. Lancet. 2010 Aug 21;376(9741):595-605. doi: 10.1016/S0140-6736(10)60888-4. Epub 2010 Jul 29. Lancet. 2010. PMID: 20673995 Clinical Trial.
A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss.
Greenway FL, Aronne LJ, Raben A, Astrup A, Apovian CM, Hill JO, Kaplan LM, Fujioka K, Matejkova E, Svacina S, Luzi L, Gnessi L, Navas-Carretero S, Alfredo Martinez J, Still CD, Sannino A, Saponaro C, Demitri C, Urban LE, Leider H, Chiquette E, Ron ES, Zohar Y, Heshmati HM. Greenway FL, et al. Among authors: fujioka k. Obesity (Silver Spring). 2019 Feb;27(2):205-216. doi: 10.1002/oby.22347. Epub 2018 Nov 13. Obesity (Silver Spring). 2019. PMID: 30421844 Free PMC article. Clinical Trial.
Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
Iyer KR, Kunecki M, Boullata JI, Fujioka K, Joly F, Gabe S, Pape UF, Schneider SM, Virgili Casas MN, Ziegler TR, Li B, Youssef NN, Jeppesen PB. Iyer KR, et al. Among authors: fujioka k. JPEN J Parenter Enteral Nutr. 2017 Aug;41(6):946-951. doi: 10.1177/0148607116680791. Epub 2016 Nov 23. JPEN J Parenter Enteral Nutr. 2017. PMID: 27875291 Free PMC article. Clinical Trial.
Obesity: why be concerned?
Brown WV, Fujioka K, Wilson PW, Woodworth KA. Brown WV, et al. Among authors: fujioka k. Am J Med. 2009 Apr;122(4 Suppl 1):S4-11. doi: 10.1016/j.amjmed.2009.01.002. Am J Med. 2009. PMID: 19410676 Review.
Office-based management of obesity.
Fujioka K, Bakhru N. Fujioka K, et al. Mt Sinai J Med. 2010 Sep-Oct;77(5):466-71. doi: 10.1002/msj.20201. Mt Sinai J Med. 2010. PMID: 20960549 Review.
440 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page